Our free mini version of the classic crossword puzzle with a business twist. Perfect for the crossword enthusiast who only has a few minutes between meetings. New puzzles go live five days a week, ...

In case you've faced some hurdles solving the clue, Original Monty Python network, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy leisure time ...

In case you've faced some hurdles solving the clue, Wii maker, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy leisure time, and test your ...

1Airport shop (4-4) 1 across. Airport shop. 4-4 letters. 5In this way (4) 5 across. In this way. 4 letters. 9Oxeye / Michaelmas flower (5) 9 across. Oxeye / Michaelmas flower. 5 letters. 10Having lost ...

CNET editor Gael Fashingbauer Cooper, a journalist and pop-culture junkie, is co-author of "Whatever Happened to Pudding Pops? The Lost Toys, Tastes and Trends of the '70s and '80s," as well as "The ...

OpenAI announced Thursday that it has entered into an agreement to acquire Astral, the company behind popular open source Python development tools such as uv, Ruff, and ty, and integrate the company ...

Last week, The New York Times launched the Midi, our daily medium-size crossword. By Ian Livengood Ian Livengood is a puzzle editor at The Times who works on Pips and the Midi. This article contains ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generate:Biomedicines raised ...